Leveraging Patient Data for Real‐Time Inter‐Instrument Comparison: Performance of the EWMA ‐Based PBRTQC Model on Triglyceride Measurements
Journal of Clinical Laboratory Analysis · 13.11.2026
DOI: 10.1002/jcla.70392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 13.11.2026. Verfasst von Xinyan Yao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Peking University First Hospital, Beijing, China. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Peking University First Hospital Research Seed Fund, Ministry of Education, China University Industry-University-Research Innovation Fund.
Abstract (Originalsprache)
Background
Patient‐based real‐time quality control (PBRTQC) offers cost‐effective, continuous monitoring, but its application for multi‐instrument harmonization within large healthcare systems remains underexplored. This study evaluated the feasibility of using PBRTQC for inter‐instrument comparison using triglyceride (TG) measurements.
Methods
From 286,855 patient TG results across two campuses of Peking University First Hospital, 245,299 valid records were extracted. PBRTQC modeling utilized the exponentially weighted moving average (EWMA) algorithm. In parallel, fresh plasma samples from 60 patients covering a wide concentration range were collected, and inter‐instrument comparison was carried out on six biochemical analyzers following CLSI EP9‐A2 guidelines. The relative differences derived from EWMA means were compared with those from two‐level conventional internal quality control (IQC) (Levels 1 and 2) on daily, weekly, and monthly bases, using half the total allowable error (TEa = ±7%) as the acceptability threshold.
Results
Big‐data‐driven comparison yielded relative differences for five comparator analyzers against the reference system ranging from −2.05% to 2.39%. The conventional EP9‐A2 comparison using 60 fresh plasma samples also showed excellent correlations ( r ≥ 0.9991), with all relative differences within the predefined acceptable limit. Over daily, weekly, and monthly trends, the EWMA mean trajectories closely paralleled those of conventional IQC means. These findings indicate that EWMA‐derived conclusions align well with fresh specimen assessments, providing a robust method for monitoring cross‐instrument analytical comparability.
Conclusions
PBRTQC using the EWMA algorithm enables continuous tracking of cross‐instrument analytical performance. It serves as an effective adjunct for evaluating inter‐instrument variations and strengthening multi‐campus quality control.
Autor:innen und Institutionen
- Department of Clinical Laboratory, Peking University First Hospital, Beijing, China.
- Department of Laboratory Medicine, State Key Laboratory of Complex, Severe, and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
ORCID-Profile: Xinyan Yao, Yuxin Wu
Förderung
- Peking University First Hospital Research Seed Fund
- Ministry of Education, China University Industry-University-Research Innovation Fund
Zitieren
APA
Yao, X., Wu, Y., Yang, H., & Guan, J. (2026). Leveraging Patient Data for Real‐Time Inter‐Instrument Comparison: Performance of the EWMA ‐Based PBRTQC Model on Triglyceride Measurements. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70392
Vancouver
Yao X, Wu Y, Yang H, Guan J. Leveraging Patient Data for Real‐Time Inter‐Instrument Comparison: Performance of the EWMA ‐Based PBRTQC Model on Triglyceride Measurements. Journal of Clinical Laboratory Analysis. 2026. doi:10.1002/jcla.70392
BibTeX
@article{Yao2026,
author = {Yao, Xinyan and Wu, Yuxin and Yang, Hongyun and Guan, Jie},
title = {Leveraging Patient Data for Real‐Time Inter‐Instrument Comparison: Performance of the EWMA ‐Based PBRTQC Model on Triglyceride Measurements},
journal = {Journal of Clinical Laboratory Analysis},
year = {2026},
doi = {10.1002/jcla.70392}
}
EUVIMED